{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T10:37:45Z","timestamp":1774348665480,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T00:00:00Z","timestamp":1359072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:p>Four patients experienced visual hallucinations that appear to have been precipitated by lisinopril. Other cases of visual hallucinations have been reported with other angiotensin\u2010converting enzyme (ACE) inhibitors. Older patients, particularly those with a history of either dementia or mild cognitive impairment, may be at higher risk. Hallucinations resolved within 1 to 30\u00a0days after cessation of <jats:styled-content style=\"fixed-case\">ACE <\/jats:styled-content>inhibitors. Development of visual hallucinations after initiation of <jats:styled-content style=\"fixed-case\">ACE <\/jats:styled-content>inhibitors should prompt discontinuation of therapy. Visual hallucinations have been reported in one case involving an <jats:styled-content style=\"fixed-case\">ARB<\/jats:styled-content>. Visual hallucinations have not been associated with direct renin inhibitors. Consideration should be given to use of alternative, unrelated antihypertensive drug classes.<\/jats:p>","DOI":"10.1111\/jch.12063","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T16:00:25Z","timestamp":1359129625000},"page":"230-233","source":"Crossref","is-referenced-by-count":15,"title":["Visual Hallucinations Related to Angiotensin\u2010Converting Enzyme Inhibitor Use: Case Reports and Review"],"prefix":"10.1111","volume":"15","author":[{"given":"John","family":"Doane","sequence":"first","affiliation":[{"name":"Department of Medicine Division of General Internal Medicine University of Utah Health Sciences Center Salt Lake City UT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Stults","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of General Internal Medicine University of Utah Health Sciences Center Salt Lake City UT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,1,25]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.01.008"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.009"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00508.x"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2010.03.001"},{"key":"e_1_2_11_6_1","first-page":"1","article-title":"Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials","volume":"6","author":"Mancia G","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_11_7_1","first-page":"963","article-title":"Doctor, there's a fly in my soup! Angiotensin\u2010converting enzyme inhibitors, endogenous opioids and visual hallucinations","volume":"3","author":"Rabinowitz I","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.69.809.240"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.2000.48.11.1533"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.2.270a"},{"key":"e_1_2_11_11_1","first-page":"8","article-title":"Captopril \u2010 psychosis","volume":"50","author":"Swedish Adverse Reactions Committee","year":"1988","journal-title":"Bull SADRAC"},{"key":"e_1_2_11_12_1","first-page":"83","article-title":"Visual hallucinations after quinapril","volume":"112","author":"Walker A","year":"1999","journal-title":"N Z Med J"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198903000-00035"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-6080(89)80026-1"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.6.759"},{"key":"e_1_2_11_16_1","first-page":"769","article-title":"Almost complete protection from [Met5]\u2010enkephalin\u2010Arg6\u2010Gly7\u2010Leu8 (Met\u2010enk\u2010RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon","volume":"281","author":"Hiranuma T","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00527-9"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.175"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.1391"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2012.08.004"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/2.4.294"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000177156"},{"key":"e_1_2_11_23_1","unstructured":"The Use of Medicines in the United States: Review of 2010. IMS Health National Prescription Audit.2010."},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.62.1.16"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.15.1934"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70295-3"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjch.12063","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjch.12063","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.12063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T02:03:21Z","timestamp":1698631401000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.12063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,25]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1111\/jch.12063"],"URL":"https:\/\/doi.org\/10.1111\/jch.12063","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,25]]}}}